Bob Curry is the CEO of PerceptiMed, Inc. and a Venture Partner of Latterell Venture Partners. He was also a General Partner of Alliance Technology Ventures and, prior to that, a General Partner and Managing Director of the Sprout Group, the venture affiliate of Donaldson, Lufkin, and Jenrette. He has served in various capacities with Merrill Lynch R&D Management, Merrill Lynch Venture Capital, Becton Dickinson, and Bio-Rad Laboratories; consulted for DuPont Instrument Products; and taught at the University of Delaware.
Curry serves on the boards of Emerald Biosciences, Inc.; the Center for Excellence in Education; and the Dean’s Advisory Council, School of Science, at Purdue University.
He received his PhD in chemistry from Purdue University, where he was a SmithKline Fellow, and his Bachelor of Science in physics from the University of Illinois, where he was an Edmund James Scholar.